2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Infections, Respiratory: new trials by email Literature Review of Infections, Respiratory trials Research Report on Infections, Respiratory
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults BNT162a1, BNT162b1, BNT162b2 - Infections, Respiratory, Virus Diseases | Phase 1 / Phase 2 | Completed | BioNTech SE | 512 | 2020-04-23 | 2024-07-12 |
| PA Tolerability, Safety and Pharmacokinetics in Healthy Volunteers Potentiator of antibiotics (PA), Placebo PA - Infections, Respiratory | Phase 1 | Completed | Scientific Center for Anti-infectious Drugs, Kazakhstan | 72 | 2016-06-17 | 2019-11-22 |
Respiratory Tract Infections (2) · COVID-19 (1) · RNA Virus Infections (1) · Severe Acute Respiratory Syndrome (1) · Virus Diseases (1)
Infections (2) · Respiratory Tract Diseases (2) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1)
BNT162 Vaccine (1)
BioNTech SE (1) · Scientific Center for Anti-infectious Drugs, Kazakhstan (1)
Germany (1) · Kazakhstan (1)